Global Heart Pump Devices Market, By Product ( Ventricular Assist Devices (VADs), Intra-aortic Balloon Pumps (IABPs), Total Artificial Heart (TAH)), Type ( Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), Therapy ( Bridge-to-transplant (BTT), Bridge-to-candidacy (BTC), Destination Therapy (DT), Other Therapies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa)-Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Heart Pump Devices Market
The heart pump devices market is expected to witness market growth at a rate of 20.37% in the forecast period of 2022 to 2029. Data Bridge Market Research report on heart pump devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the heart failure morbidity and mortality, especially in the developing countries is escalating the growth of heart pump devices market.
Heart failure is known to be a condition in which the heart is incapable of pumping enough bloodss to meet the body's need. Such syndrome may happen due to several factors, such as pre-myocardial infarction (heart attack), high blood pressure, atrial fibrillation, heart disease, and others, including coronary artery.
Major factors that are expected to boost the growth of the heart pump devices market in the forecast period are the rise in the incidence of cardiovascular diseases and the increasing in the aging population. Furthermore, the rise in the patient population that are affected with heart disorders is further anticipated to propel the growth of the heart pump devices market. Moreover, the increasing penetration by market players is further estimated to cushion the growth of the heart pump devices market. On the other hand, the increased cost of heart pump devices is further projected to impede the growth of the heart pump devices market in the timeline period.
In addition, the shortage in the number of heart donors will further provide potential opportunities for the growth of the heart pump devices market in the coming years. However, the poor reimbursement scenario in the advancing nations might further challenge the growth of the heart pump devices market in the near future.
This heart pump devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the heart pump devices market, contact Data Bridge Market Research for an Analyst Brief, Our team will help you take an informed market decision to achieve market growth.
Global Heart Pump Devices Market Scope and Market Size
The heart pump devices market is segmented on the basis of product, type and therapy. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of product, the heart pump devices market is segmented into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs) and total artificial heart (TAH). Ventricular assist devices (VADs) are further segmented into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), bi-ventricular assist devices (BiVADs) and percutaneous ventricular assist devices (PVADs).
- On the basis of type, the heart pump devices market is segmented into implantable heart pump devices, extracorporeal heart pump devices.
- On the basis of therapy, the heart pump devices market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), other therapies.
Heart Pump Devices Market Country Level Analysis
The heart pump devices market is segmented on the basis of product, type and therapy.
The countries covered in the heart pump devices market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Americas dominates the heart pump devices market due to the rise in the incidence of cardiovascular diseases and the growing of more elderly population. Furthermore, the increase in the initiatives taken by the government, funding for research and development in advanced medical treatment options will further boost the growth of the heart pump devices market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the heart pump devices market due to the rise in the incidence of chronic cardiovascular disorders and growing healthcare expenses. Moreover, the rising standard of living is further anticipated to propel the growth of the heart pump devices market in the region in the coming years.
The country section of the heart pump devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The heart pump devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the heart pump devices market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the heart pump devices market. The data is available for the historic period 2010-2020.
Competitive Landscape and Heart Pump Devices Market Share Analysis
The heart pump devices market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the heart pump devices market.
Some of the major players operating in the heart pump devices market are Terumo Medical Corporation, W. L. Gore & Associates, Inc., lepumedical.com, Getinge AB., Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Berlin Heart, CardiacAssist, Inc, ReliantHeart Inc., Fresenius Medical Care AG & Co. KGaA Jarvik Heart, Inc., SynCardia Systems, LLC, ABIOMED, HeartWare, CryoLife, Inc., and Teleflex Incorporated among others.
SKU-